FMT for Multidrug Resistant Organism Reversal
Use of Fecal Microbiota Transplantation (FMT) to Reverse Multi-Drug Resistant Organism Carriage
Sponsor: Washington University School of Medicine
A PHASE1 clinical study on Infection With Multi-drug Resistant Organisms, this trial is completed. The trial is conducted by Washington University School of Medicine and has accumulated 13 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE1
-
Mar 2021 — Dec 2022 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
▶ Show 8 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE1
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
Status: Enrolling By Invitation → Active Not Recruiting
-
Aug 2019 — Jun 2020 [monthly]
Enrolling By Invitation PHASE1
-
Jun 2018 — Aug 2019 [monthly]
Enrolling By Invitation PHASE1
-
Dec 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE1
Status: Unknown Status → Enrolling By Invitation
-
Sep 2017 — Dec 2017 [monthly]
Unknown Status PHASE1
Status: Enrolling By Invitation → Unknown Status
-
Feb 2017 — Sep 2017 [monthly]
Enrolling By Invitation PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE1
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.